Clemson University

TigerPrints
All Theses

Theses

12-2010

INFLUENCE OF TOPOGRAPHY OF
ENDOVASCULAR STENT MATERIAL ON
SMOOTH MUSCLE CELL RESPONSE
Vipul Taneja
Clemson University, vtaneja@clemson.edu

Follow this and additional works at: https://tigerprints.clemson.edu/all_theses
Part of the Biomedical Engineering and Bioengineering Commons
Recommended Citation
Taneja, Vipul, "INFLUENCE OF TOPOGRAPHY OF ENDOVASCULAR STENT MATERIAL ON SMOOTH MUSCLE CELL
RESPONSE" (2010). All Theses. 983.
https://tigerprints.clemson.edu/all_theses/983

This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized
administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.

INFLUENCE OF TOPOGRAPHY OF ENDOVASCULAR STENT MATERIAL ON
SMOOTH MUSCLE CELL RESPONSE

A Thesis
Presented to
The Graduate School of
Clemson University

In Partial Fulfillment
of the Requirements for the Degree
Master of Science
Bioengineering

by
Vipul Taneja
December 2010

Accepted by:
Dr. Martine LaBerge, Committee Chair
Dr. Alexey Vertegel
Dr. Eugene Langan III

i

ABSTRACT

Although implantation of endovascular stents for the treatment of coronary and
peripheral artery diseases has been one of the most rapidly used medical interventions,
significant limitations in terms of a restenosis rate of 10-30% still persists. Neointimal
hyperplasia characterized by a phenotypic shift of smooth muscle cells from contractile to
synthetic type, has been deemed to be the predominant cause of restenosis. A number of
stent surface parameters, including topography, have been attributed to play an important
role in stent performance. Although endothelial cell and thrombotic response to surface
roughness have been well evaluated, the effect of topography of the outer stent struts on
smooth muscle cells has not been reported yet. The objective of this study, therefore, was
to examine the effects of topography of a regularly used endovascular stent material
(316L stainless steel) on smooth muscle cell phenotype as an indicator of neointimal
hyperplasia and restenosis.

A model simulating the contact of stent material in the arterial wall was
developed by utilizing 316L stainless steel of varying topography. Topography of as
received 316L stainless steel was modified to get electropolished and micro-grooved
surfaces using electropolishing and metallographic grinding respectively. Surface
characterization was done using non contact profilometry, EDS and SEM. Cell
morphology was analyzed using confocal microscopy, while a standard cell proliferation
assay and DAPI cell counting were employed to study cellular growth. Also, a cell based
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ELISA assay was developed to quantify smooth muscle α-actin expression as a marker of
contractile phenotype of smooth muscle cells.

It was observed that cells grown on micro-grooved surfaces were significantly
more elongated than the cells on both of the other surface types. Ascertained by repeated
proliferation studies, cells grown on micro-grooved surface demonstrated as much as
44% lower cell count when compared to the electropolished surface. Results of ELISA
assay indicated upto 63% higher α-actin expression in cells cultured on micro-grooved
surface compared to the electropolished surface. Furthermore, cells on electropolished
surface demonstrated a loss of 47% smooth muscle α-actin content per cell between day1
and day 4, while that on micro-grooved surface remained the same.

Since contractile smooth muscle cells are characterized by elongated spindle
shaped morphology, low proliferation rate, and high α-actin expression, our results
suggest that micro-grooves on 316L stainless steel promote contractile phenotype in
smooth muscle cells when compared to the current industry standard - electropolished
surface.
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CHAPTER ONE

INTRODUCTION AND BACKGROUND
1.1 Introduction

Cardiovascular diseases are the leading cause of mortality in the United States and
Europe, accounting for approximately half of all deaths [1,2]. Furthermore, coronary
heart disease accounts for more than 50% of all the deaths due to cardiovascular diseases
making it the single leading cause of death in United States today [3]. Atherosclerosis
which is a progressive build up of atheromatous plaque in arteries has a preference for
developing in coronary arteries leading to coronary artery disease. This condition is
commonly treated using balloon angioplasty which, in most cases, is done in conjunction
with the deployment of a metallic stent. Stents exert a continuous radial pressure on the
diseased artery resulting in compression of atherosclerotic plaques and thus assist in
maintaining vessel patency. Although implantation of stents for the treatment of coronary
and peripheral artery diseases has been one of the most rapidly used medical
interventions, significant limitations in terms of restenosis (re-narrowing of stented
artery) rate of 10-30% still persist [4]. This makes research into the improvement of stent
design a very important endeavor.

A number of strategies have been proposed to optimize stent performance including
drug loaded polymer coatings, pre-endothelialization of stents, gene delivery, and
variations in stent geometry to name a few [5-8]. However, none of these strategies have
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been completely successful in eradicating the problem of restenosis. This might be
related to the current lack of a basic understanding of how a biomaterial interacts with the
tissues at a cellular or a molecular level. Therefore, in order to improve stent
performance, one must gain an understanding of the fundamental interactions between a
stent/coating surface and the vessel wall. This understanding can then be used in an
effort to optimize various parameters of stent design in order to minimize occurrence of
restenosis.

Since the interface between the host tissue and foreign biomaterial plays an important
role in implant biocompatibility, recent research in implant design has been focused on
studying and engineering implant surface properties. The specific chemistry and
topography of a biomaterial surface determine how the living host tissue interacts with
the implant. Starting nanoseconds after implantation, proteins adsorb on the implant
surface, and this adsorption is affected by the surface chemical nature and topographical
features [9]. Surface-bound proteins may then mediate cell interaction dictating cell
response. Numerous studies have documented that substratum topography affects the
ability of cells to orient, migrate, proliferate, and to even induce changes in gene
expression [10-11]. The application of micro- and nanotechnology, therefore, to the
biomedical arena has brought a tremendous potential in terms of developing new
diagnostic and therapeutic modalities.
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Although microfabrication was mainly applied to semiconductor materials,
techniques to translate micromachined structures from inorganic to organic polymeric
materials were only introduced by Brunette in 1986 [12]. Since then, several different
techniques have been developed to create micro and nano-structured surfaces [13-14]
opening up tremendous opportunities in substrate development for medical implant
design.

This chapter will take a systematic approach to gaining an understanding of vascular
stenting as the primary modality for treatment of atherosclerosis, and the major
complication of using vascular stents, neointimal hyperplasia leading to restenosis. This
chapter also attempts to simplify the direct mechanotransductive pathways explaining
how mechanical forces may be transduced to the cell nucleus and the current thinking as
to how the nucleus turns these mechanical cues arising from topography into changes in
cell behavior. Cellular response to synthetic topography is then discussed with an
emphasis on vascular cells for synthetic vascular graft applications. Finally, the emphasis
on the need to evaluate effects of surface topography of outer stent surface on smooth
muscle cell (SMC) response is laid. A detailed understanding of these interactions could
ultimately offer a powerful intrinsic tool to control the adverse SMC response seen
during in-stent restenosis.

3

1.2 Endovascular stents

Predominant treatment options for atherosclerosis include bypass grafting, balloon
angioplasty, and endovascular stenting. While bypass grafting is mainly limited by
available autologous veins or arteries, efficacy of balloon angioplasty is questionable
with a restenosis rate of 30-40% [4]. Stents, which are commonly metallic, lattice-like
scaffolds are inserted into stenosed arteries following balloon angioplasty, thereby
exerting a continuous radial pressure on the diseased artery wall resulting in compression
of atherosclerotic plaques and thus in maintaining vessel patency.

Even though introduced in the 1960‘s, endovascular stents have triggered a
substantial interest in the last two decades because of the high frequency of restenosis or
re-closure of the vessel lumen. Stents have found extensive use in coronary applications,
predominantly because of the fact that coronary arteries are the most common site for
endovascular stent insertion and thus the enormous investment by stent manufacturing
companies in developing coronary stents. However, with increase in peripheral occlusive
diseases, increasing focus is being put on developing specialized stents, such as drug
eluting stents (DES) for peripheral arteries as well.

Several criteria are important for stent design including biocompatibility, flexibility,
radial strength, percentage of lesion covered, radio-opacity, minimal shortening at the
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opening, cost, and surface properties such as topography, composition, freeenergy/hydrophobicity, heterogeneity, and electrical potential [15-16].

Stents can be classified on the basis of a number of parameters. Based on geometry,
stents can be wire mesh, slotted tube, ring, coil, or corrugated ring type. Based on method
of deployment, stents can be divided into two major classes: (i) balloon expandable
stents, and (ii) self expandable stents. Balloon expandable stents are manufactured in a
crimped state and expanded in the vessel using a balloon. Self-expanding stents, on the
other hand, are manufactured at the vessel diameter (or slightly above) and are crimped
and constrained to a smaller diameter until the time of deployment, where the constraint
(usually a sheath) is removed and the stent deployed.

Stents can also be distinguished into bare-metal or coated stents. Polymer coated
drug eluting stents are discussed in the next section. Although drug eluting stents came
up as an improvement to bare metal stents by limiting restenosis, they appear to invoke a
thrombogenic response that leads to late thrombosis and eventual vessel occlusion [17].
A new generation of stents in the form of biodegradable stents offers a promising
alternate to permanent metal stents, by presenting a way to deliver greater amount and
controlled release of drugs, while being degraded when they have scaffolded the vessel
for a substantial period of time. However, there are still pertinent issues regarding
inflammation, mechanical properties, and toxicity that need to be addressed before the
bright future of bio-degradable stents can be realized [18].
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1.3 In-stent restenosis and drug-eluting stents (DES)

Following stent deployment, it is common to experience significant local damage to
the inner most lining of arteries, the endothelium. This injury often results in a near
complete denudation of the endothelial layer [19] which is manifested in the exposure of
underlying thrombogenic collagen and sub-endothelial matrix that is accompanied by the
loss of inhibitory effects of the endothelium on thrombus formation [15]. With the use of
anticoagulant and anti-platelet therapy, thrombolization to such an extent as to occlude
the vessel lumen is relatively rare. However, thrombus formation and inflammation
process going on at the site of stenting which leads to high local concentration of growth
factors such as cytokines and platelet-derived growth factor (PDGF) triggers a mitogenic
and chemotactic response from SMCs [17]. It should be noted that the loss of
endothelium also exposes the underlying medial layer of arteries to not only shear force
due to blood flow but also to mechanical loading due to tightly appositioned stent struts.
The over proliferation of smooth muscle cells to the various afore mentioned stimuli
coupled with copious amounts of extracellular matrix (ECM) that these cells produce
forms a neointimal tissue generally known as intimal hyperplasia which has been
regarded as one of the major mechanisms responsible for restenosis. Figure 1 depicts the
progression of in-stent restenosis.
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Figure1: Proposed mechanism of restenosis (adapted20)

Intimal hyperplasia which is clearly one of the major mechanisms responsible for
restenosis is largely caused by a change in phenotype of vascular smooth muscle cells
from a quiescent contractile phenotype to a proliferative synthetic phenotype [21-23].
Contractile SMCs are quiescent, morphologically smaller (figure 2) and more elongated
than their counterpart. They demonstrate low migration, proliferation, and ECM protein
synthesis.
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Figure 2: Morphology of contractile and synthetic SMCs (adapted25)

Additionally, contractile SMCs express relatively higher levels of contractile proteins
such as smooth muscle α-actin, calponin, myosin heavy chain and smoothelin, which
contribute to the cells‘ ability to contract [24-25]. In contrast, synthetic SMCs are marked
by large morphology, higher cell proliferation, increased extracellular matrix production,
and loss of the ability to contract. Thus, blocking of SMC proliferation and/or the overall
phenotype shift from contractile to synthetic is seen as a useful way to reduce the
incidence of restenosis and has been a major motivation for the development of drugeluting stents.
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Drug eluting stents (DES) rely on the delivery of drugs from a polymer coating on the
stent with targets including cell proliferation and migration, inflammation and platelet
activation [74]. Polymers that have been the recent subject of experimental testing as
stent coating materials include polyethylene-co-vinyl acetate (PEVA), poly n-butyl
methacrylate (PBMA), phosphorycholine (PC), polycaprolactone (PCL), poly(styrene-bisobutylene-b-styrene), poly lactic acid-co-glycolic acid (PLGA) etc [28,30]. While DES
have been shown to reduce in-stent restenosis [26-27], in no study published to date has
the use of drug-eluting stents reduced mortality or myocardial infarction. This is in all
likelihood because with a delay in growth and migration of smooth muscle cells, these
drugs also bring about a simultaneous delay in re-endothelialization, potentially
increasing the chances of acute and late thrombus formation [29].

1.4 Topography and mechanotransduction

It is well understood that that cells react to the topographic structure of their
environment. The term ―cell guidance‖ was first introduced by Weiss and Garber in 1952
[31] to describe how cells follow a topographical cue. In reaction to grooved topography
in particular, cell guidance is believed to occur when cells are inhibited from crossing a
step, and rather follow the step edge generally becoming elongated and aligned [10].
How the cells perceive such steps or other topographical features can be explained with
the principles of mechanotransduction, the mechanism by which cells convert mechanical
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signals into biochemical responses. For topography, these forces are considered to be
generated by changes in cell spreading.

Such changes in cell morphology/spreading due to topographical cues can be
attributed to two antagonist processes: (1) active force generation through conversion of
chemical energy, and (2) passive resistance of the cell and reactive forces [31]. Some
examples of the first category include contractile forces generated at cell-substrate
contact [32], and active protrusive forces arising from polymerization of cytoskeleton
elements [33], which for example drives lamelliopodium extension in fibroblasts or axon
growth in neurons [31]. In the second category, lie all the mechanical processes that resist
the described active forces, for example the viscoelastic strength of the overall cell
structure. Another example in the second category would be the reactive forces that a cell
would experience while attached to a topographical cue (Newton‘s third law of motion
which states that ―for every action, there is an equal and opposite reaction.‖), which
would be consequently exerted on the cell membrane and transmitted to the rest of the
cell via its cytoskeleton [34]. These active processes as well as reactive forces have been
shown to affect organelle displacement including deformation of nucleus [35]. Changes
in shape of nucleus may, in turn, alter the rate of transport of molecules through nuclear
pores, and/or chromosome positioning etc. [36] which could ultimately affect many
aspects of cell behavior. By what routes do these mechanical effects alter cellular
behavior is what the principles of mechanotransduction attempt to explain.
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1.4.1 Cell shape governs cell fate

Cell shape changes with changes in mechanical forces that a cell is subjected to
[11,41]. This change is not kept to morphology alone, but has been shown to have effects
on cellular proliferation, phenotype changes, and the overall cell fate. This is highly
relevant for studying cellular response to topography, because reaction of cells to
topography is usually manifested in a change in cell shape, although it is, by no means
limited to just a change in cell shape.

Cell shape or distortion represents a visual manifestation of their underlying
physical force distributions since cells spontaneously change their shape when the
mechanical integrity of their substratum is altered. This is best explained with Ingber‘s
three-dimensional tensegrity model [38]. Thus considering the fact that applied
mechanical stimulus to cells causes change in intracellular force distribution leading to
changes in cell shape, and tying it with the observation that a variety of nuclear functions
including DNA and RNA synthesis can be controlled by perturbing cell shape [13,39], it
is likely that changes in mechanical force distribution could have substantial
consequences on cell fate in terms of apoptosis, differentiation, or growth etc. Ingber and
collaborators observed a mechanochemical response in endothelial cells by controlling
cell spreading using different densities of fibronectin as cell substratum [40]. Extensive
cell spreading on high density fibronectin (>500 ng/cm2) resulted in proliferative and

11

non-differentiated cells, while round cells on low density fibronectin (<100ng/cm2)
exhibited detachment and apoptosis.

Chen and collaborators [11] showed that cell spreading controls growth versus
apoptosis in capillary endothelial cells by using micro-patterned substrates that contained
ECM-coated adhesive islands of varying size. In their following experiments, these
authors patterned adhesive/non-adhesive regions to control cell spreading while
maintaining constant cell/ECM contact area, for increasing cell-ECM contact area might
increase integrin binding and accessibility to matrix-bound growth factors amongst other
things. They found that cell spreading or cell shape per se was the critical determinant
that switches cells between life and death and between proliferation and quiescence.
These findings indicate that controlling substrate topography could be exploited to dictate
cell shape which ultimately could determine the cell fate. An additional level of control to
direct cell behavior is presented by the proteins that adsorb on a biomaterial surface, as it
is believed that the proteins mediating cell attachment convey the underlying chemistry
and topography through their own specific geometry and conformation [14].

1.4.2 How does topography exert mechanotransductive effects on cells

As discussed earlier, topography results in changes in cell spreading. The
accompanied change in cell morphology leads to cytoskeleton tension rearrangements
[42,43]. Furthermore, the resulting changes in cytoskeleton organization that mediate cell
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spreading are driven by mechanical tension that is generated within actomyosin filaments
inside the cytoskeleton [41,44]. This balance of intracellular mechanical forces that
accompany cell spreading and drives cytoskeletal restructuring controls downstream
signaling cascades by both direct transmission of forces to the nuclei as well by indirect
routes. To this end, mechanotransduction can be divided into two major categories: direct
and indirect [45]. Direct mechanotransduction takes into account the conformational
changes in cell cytoskeleton to signal nucleus about changes in the extracellular
environment like topography, and strain etc. Indirect mechanotransduction utilizes
signaling events tied in with focal adhesions, G-proteins and tyrosine kinases etc. to relay
information to the nucleus through various signaling cascades.

The exact mechanisms by which cells sense, signal, and respond to topography
remain unclear, but direct mechanotransduction is currently being investigated in relation
to topography. Indirect mechanotransductive events in cellular response to topography,
however, have not been evaluated yet due to their intertwined nature and thus the
associated complexity.

Maniotis and collaborators [36] reported that in reaction to tension, the
intermediate filaments re-orient, the nucleus distorts and the nucleoli rearrange along the
applied axis. This shows the mechanical integration of nucleus within the physical entity
of the cell and that applied mechanical forces can lead to nuclear deformation.
Intermediate filaments and microtubules are considered to play the main roles in direct
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mechanotransduction by linking the plasma membrane to cell nucleus and acting as a
conduit for transmittal of mechanical effects from the substrate to the cell [36,46].
Dalby‘s research group [10] studied response of fibroblasts to micro-grooved
topographies and found that the cells aligned along the grooves and their nuclei were
elongated. They also reported a large number of gene expression variations after 24 hours
and 5 days compared to flat controls. These changes were predominantly in the areas of
cytoskeleton, cell signaling, extracellular matrix regulation and proliferation.

Tying in the above observations on nucleus, cytoskeleton, and topographic
interactions, Dalby and collaborators put forward a hypothesis of self induced
mechanotransduction [10]. The authors suggest that surface topography alters nuclear
morphology via direct mechanotransduction and in turn the position of the chromosomes
and subsequent down-stream events including changes in the probability of gene
transcription. To test their hypothesis, they conducted a study on fibroblasts on nanocolumns, and found that cells on the columns had a spherical nuclei compared to an ovoid
shape nuclei for cells on flat controls [10]. Centromeres in cells on nano-columns were
found to be significantly closer compared to the control. Furthermore, the cells were
shown to be more relaxed on the nano-columns compared to well-spread cells on flat
controls suggesting that less tension was applied to the nuclei of cells on the former.
Assuming, then that cellular effects to topography come mostly if not entirely from the
ability of cells to spread, it is possible that a change in chromosome position following
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mechanotransduction can lead to altered gene transcription which may manifest itself in
changes in cell growth, proliferation, apoptosis, phenotypic changes and so on.

Another potential mechanism for direct mechanotransduction in response to
topography could be that the structural changes in the nuclear envelope may influence
accessibility of transcription factors [36]. However, these are only theories, and need
further investigation to comprehend the role of direct mechanotransduction in cellular
response

to

topography.

As

well

as

direct

mechanotransduction,

indirect

mechanotransduction should also be taking place. It has been shown that integrin binding
to RGD and similar peptides can signal the G-protein and kinase based signaling events,
and produce many down-stream effects [47,48]. Thus, indirect mechanotransductive
events entail thorough investigation too.

Ultimately, how a cell responds to topography depends on size the scale of
topography - bottom-up if the grooves are in the nano range where a cell will orientate
one adhesion at a time, and top-down in case of micron level grooves where the cells are
forced to align and the adhesions will align as the cytoskeleton has to [Personal
communication with Dr. Matthew J Dalby, University of Glasgow, UK]. Either ways, it
is likely that adhesion signaling and cytoskeletal arrangements will be the key through
direct and indirect routes.
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1.5 Effects of synthetic micro and nano-structured surfaces on cell behavior

The interaction between cells and biomaterials is influenced by a number of physical
and chemical factors, of which one of the major factor is surface topography. The
influence of microtopography on cells has been known from a long time with one of the
first studies using microfabricated substrates to study cellular behavior performed by
Brunette and collaborators [49]. They demonstrated the use of a silicon mask-etching
technique to prepare grooved surfaces to control the direction of outgrowths of human
gingival explants. Subsequently, there have been many studies showing topographical
control of cells and even tissues. Surface micro and nano-topography have been shown to
modulate the cell morphology, adhesion, proliferation, migration, and differentiation for a
variety of cells including fibroblasts, osteoblasts, macrophages, hepatocyte, BHK cells,
epithelial cells, neuronal cells, endothelial cells, and smooth muscle cells. Varying
cellular responses to defined topographies for a variety of cells have been reviewed
elsewhere [13,50]. Response of vascular smooth muscle cells to topography has been
highlighted for the purpose of this review.

1.5.1 Range of phenomena

Different types of substratum topography have been shown to influence cell behavior
depending on both scale and feature type, for example micro- and nanometre scale ridges
and grooves and if there are randomly or evenly distributed features or artifacts such as
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pits or spikes [51,52]. Micro-topography has been shown to influence cell response as
these dimensions are comparable with cellular dimensions of 10-30 µm, while
nanotopography has been shown to predominantly influence cellular orientation [14,52].

1.5.2 Chemistry or topography

It becomes very important at this point to introduce a question that has been asked
repeatedly in relation to response of cells to topography. The question is whether the cells
are reacting to the topography directly or to the patterned substratum chemistry formed
during fabrication of topography (e.g. by any etching process or otherwise).

This problem has been largely answered by the work of Britland et al. [54]. These
authors used laminin as a chemical cue oriented at right angles to grooves used as
topographic cues. When the grooves were 500nm deep or less, the cells reacted chiefly to
the chemical cue. On deeper grooves, the topographic cue over-rode the chemical one
and at 5µm depth, the topographic effect oriented about 80% of the cells and the
chemical one 7%. Thus, the ability to synthesize well-controlled topographies holds the
promise to direct cell function, either without or synergistically with the use of chemical
cues.
Cellular response to topography has been studied for a wide variety of cell types and
topographical features including grooves, ridges, pores, wells, steps and aligned or nonaligned fibers etc. It is well established that different cell types will exhibit different
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behavior on different substrate topographies. Hence, the overall trends of effect of
topography on cellular response are challenging to determine and are rather cell type and
application specific. For the purpose of this review, therefore, the response of vascular
smooth muscle cells to micro and nano-topographies is being discussed.

1.5.3 Response of smooth muscle cells to topography

While commercial synthetic vascular grafts have had success in replacing large
arteries (>6mm), thrombosis and intimal hyperplasia have plagued small diameter
vascular grafts (< 6mm) causing a substantial drop in patency rate, from 95% for large
diameter vascular grafts to 30% in small diameter vascular grafts, after only 5 years [55].
Tissue engineering comes across as a promising way to synthesize functional vascular
grafts, and has led to exploration for numerous design modifications [56] to not only
achieve adequate mechanical properties, but to recapitulate the in vivo function of native
blood vessels. The medial layer provides the main structural support of the vessel and
consists of multiple layers of smooth muscle cells (SMCs) and extracellular matrix
(ECM) [57]. SMCs in native blood vessels, referred to as contractile SMCs, have a
spindle-shaped morphology and align in circumferential direction to cause vessel
constriction or dilation [57]. When cultured in vitro, these cells lose their contractility and
assume a synthetic phenotype [24-25]. Maintaining the contractile phenotype of SMCs
has long been an unsolved problem in developing tissue engineered vascular grafts
gaining significant attention in the last 2 decades. To this end, a number of studies have
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reported the potential of topography in forming a defined architecture to guide SMC
growth and development as needed. Additionally, Thakar and collaborators [58]
demonstrated the potential use of micro-patterning for controlling SMC phenotype,
alignment, and proliferation to produce functional tissue-engineered PLGA vascular
grafts. Selected studies to control SMC growth and differentiation with topographical
cues are summarized in Table1.
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Table 1 Selected references showing effect of topographical features on smooth muscle cells

Cell type [Ref]

Feature type Fabrication
method
Stochastic
Treatment with
roughness
NaOH, casting with
Sylgard followed by
PLGA casting
Stochastic
Compacted
roughness
nanoparticles
Aligned
Electrospinning
fibers

Material

Bovine
pulmonary
artery [62]

Nanogratings Nano imprint
lithography,
molding

PMMA,
PDMS

Human aortic
[63]

Grooves

Soft-lithography

PDMS

Human
coronary artery
[64]
Human
umbilical [65]
Human aortic
[66]

Grooves

Photolithography

PDMS

Grooves

Photolithography,
soft-lithography
Deep reactive ion
etching

PDMS

Bovine aortic

Grooves

Microfluidic

Collagen,

Rat aortic [59]

Rat aortic [60]
Human
coronary artery
[61]

Channels
with
discontinuou
s walls

PLGA

Cp Ti,
CoCrMo
P(LLA-CL)

PLGA
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Feature
dimensions
Nano-structured;
exact dimensions
not listed

Cellular response
Enhanced cell proliferation &
adhesion

Nano-structured

Increased adhesion, spread
morphology
500nm diameter,
Cells aligned & migrated along
random spacing
fibers; were spindle shaped;
showed less proliferation
compared to control surfaces
350nm linewidth,
Significant elongation &
700nm pitch,
alignment in cytoskeleton &
350nm depth
nuclei compared to nonpatterned control
10µm wide, 2.8µm Elongated morphology, lower
deep
proliferation rate compared to
planar control
2-10µm wide, 50- Elongated morphology,
200nm deep
migration along grooves
20-80µm wide,
5µm deep
300µm wide,
microwall 60µm
high, 160µm long,
separated by 40µm
gaps
20,30,50 um wide

Elongated morphology, actin
filaments aligned along grooves
Elongated morphology,
contractile phenotype at
confluence

Decreased proliferation, cell

[58]

Rat aortic [67]

Threedimensional
microchannels

patterning,
photolithography

PLGA

Deep reactive ion
etching

PCLLGA

PLGA: poly(lactic-co-glycolic acid); P(LLA-CL): poly(

10-160 um wide,
10/25 um thick
walls, 65um deep

shape index, expression of αactin on 20 & 30 um collagen;
similar results for PLGA with 30
um groove width
Cells in wider micro-channels
(80-160um) showed elongated
morphology, contractile
phenotype compared to control
surfaces.

-lactid-co-ε-caprolactone); PMMA: poly(methyl methacrylate);

PDMS: poly(dimethylsiloxane); PCLLGA: poly(ε -caprolactone-r-L-lactide-r-glycolide) diacrylate; ECM: extra cellular matrix
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1.6 Implications for endovascular stent applications

Stents are metallic, lattice-like scaffolds that are inserted into stenosed arteries
thereby exerting a continuous radial pressure on artery wall resulting in compression of
atherosclerotic plaques and thus maintaining vessel patency. The major problem
associated with use of stents is re-narrowing of the treated artery called in-stent restenosis
which occurs in 10-30% of all stent procedures [4]. This has led to the development of
drug eluting stents as well as other strategies aimed at limiting neointimal hyperplasia
and thrombosis- the two major determinants of clinical restenosis. Since anti-platelet
therapy is used to limit thrombogenesis, most of the research in this regard has been
aimed at limiting neointimal hyperplasia which is caused by SMC hyperplasia, and
migration following endothelium denudation caused during stent deployment [17]. Thus,
majority of the strategies to improve the performance of stents have been aimed to either
promote stent strut endothelialization, or to limit smooth muscle cell migration,
proliferation and an overall phenotypic change from contractile to synthetic type.

In relation to endovascular stents, the degree of smoothness or flatness has been
the choice of investigation for a long time. It has been shown that polishing of coronary
stents results in decreased thrombogenicity as well as neointimal hyperplasia in different
animal models [68,69]. Recent investigation of influence of stent topography on
endothelial cells, however, revealed conflicting results with rough stent surfaces showing
accelerated endothelialization rate and similar to lesser restenosis when compared to
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smooth stent surfaces in both in-vivo and in-vitro studies [70-73]. Palmaz et al. [70]
observed that surface grooves at microscopic scale influence the conformation and
migration of endothelial cells and concluded that the endothelial cell migration rates
significantly increased on surfaces with grooves ranging from 3 to 22µm with a
maximum at surface with 22µm grooves compared to the flat control surfaces. In another
study [71] stents with micron level parallel grooves were placed in carotid arteries of
pigs. It was reported that at 1 week after implantation, textured surfaces exhibited an
endothelialization rate almost double that observed on stents with smooth surfaces. Dibra
and collaborators [72] conducted the first clinical study to evaluate the relationship
between stent surface topography and outcome in patients undergoing implantation of
electrochemically polished and sand blasted stochastically rough stent surfaces. They
observed that both types of stents were equivalent with respect to late lumen loss but the
results indicated a reduced restenosis for the sand blasted stent surface as compared to
smooth electrochemically polished stents. Very recently, Choubey and research group
[73] studied the response of endothelial cells to stainless microstructure and reported an
increased endothelial cell density on stainless steel specimens with 16µm grain size when
compared to larger grain sizes specimens.

As discussed in the previous section, response of SMCs to texture has been evaluated
for polymeric surfaces potentially for vascular graft applications. However, to the
author‘s best knowledge, response of stent strut roughness on smooth muscle cells has
not yet been reported. It has been well established that stent deployment causes injury to

23

the blood vessel including endothelium denudation. This subjects the underlying smooth
muscle cells to additional mechanical forces, either from a stent strut or due to shear from
blood flow, which they usually do not experience in healthy arteries. It, therefore,
becomes pertinent to analyze how these cells respond to the new mechanical stimuli and
if it has a role in the development of neointimal hyperplasia. It should be noted that with
the mechanical stimuli, the cells also get exposed to blood components and circulating
growth factors, cytokines etc. which would affect the progression of restenosis as well.

SMCs have been shown to experience a phenotypic change from a quiescent
contractile phenotype to a synthetic phenotype following stenting [21]. Increased
proliferation of synthetic SMCs, and the copious amount of ECM they produce soon
starts obstructing the blood flow to progress restenosis. What effect does
shear/mechanical loading due to tightly appositioned struts has on smooth muscle cell
proliferation, migration, and the overall phenotypic change is a question that needs to be
addressed in order to improve the stent design. Assuming that cells do respond to altered
mechanical forces, another question that finds relevance here is that ―What are the
mechanisms involved in signal transduction- direct mechanotransduction or indirect
signaling?‖ Once deciphered, the information could be used to control this signal
transduction and thus cell fate.
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1.7 Conclusion

In conclusion, the chapter introduced vascular stents, the problem of restenosis,
and tried to explain how cells respond to topography, in particular by direct
mechanotransduction, what effect does micro and nano-topography has on cells,
particularly endothelial and smooth muscle cells, and finally the need to investigate and
control smooth muscle cell response to stent topography. Clearly, controlling substratum
topography represents a powerful intrinsic method to control the abilities of cells to
orient, migrate, and proliferate, as documented by the studies summarized above. Thus,
after careful investigation of response of SMCs to defined stent topographies by both
direct and indirect mechanotransductive pathways, their morphology, cytoskeleton and
the gene expression could potentially be directed to limit neointimal hyperplasia and
ultimately clinical restenosis.
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CHAPTER TWO

RESEARCH RATIONALE
2.1 Overview

Intimal hyperplasia is triggered by endothelium denudation caused during stent
deployment and advanced with the subsequent smooth muscle cell hyperplasia and
hypertrophy [15,17,19,21]. The limitations and problems associated with the clinically
used stents, therefore, provides the impetus for exploration of pro-healing therapeutic
strategies that prevent smooth muscle migration, proliferation, or the overall phenotypic
shift without delaying stent strut and inter-strut re-endothelialization, with the overall
objective of maintaining vessel patency.

Topography, as discussed in Chapter 1, has been shown to affect SMC phenotype,
proliferation, and alignment. This study was designed to study the effects of microgrooves on the surface of one of the most commonly used intravascular stent material
316L stainless steel on qualitative (contractile vs. synthetic phenotype) as well as
quantitative (cell proliferation) smooth muscle cell response. As seen in some of the
research with textured polymers, if cells become spindle-shaped in the grooves, it is
possible that direct mechanotransduction could alter gene transcription and result in a
phenotype shift. A decrease in proliferation due to restrictions of spreading could also be
caused. Or, the cells could just be elongated, without any phenotypic change as seen by
Thakar and collaborators [24] However, the response of SMCs to textured stent could
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very well be different from that observed with polymers, and could manifest itself in a
different response because of the concurrent inflammation process going on at the site of
stenting.

Prospective use of topographical cues for stent application, particularly in relation
to the outer surface, remains to be evaluated. This project aimed at exploring the potential
of topographical cues embedded on stent surface as an implicit way to direct smooth
muscle cell response to prevent restenosis. As discussed previously, SMCs are believed
to experience a phenotypic shift from a contractile to a synthetic phenotype following
stent deployment. Spindle shaped contractile cells which have been shown to proliferate
slowly, and produce less ECM represent a more favorable phenotype compared to their
rapidly proliferating counterpart – synthetic SMCs. This shift in phenotype was studied
for SMCs grown on different topographies of 316L stainless steel, with an overall
objective of researching optimal stent strut topography to preserve contractile phenotype
of smooth muscle cells.

2.2 Specific Research Hypothesis:

We postulated that micro-grooves on 316L stainless steel would affect smooth
muscle cell response manifested in cell morphology, cell proliferation, and cell
phenotype.
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Contractile smooth muscle cells are characterized by low cell proliferation,
elongated spindle shaped morphology, and high expression of contractile markers such as
α-actin. These three characteristics of smooth muscle cells were evaluated and compared
against cells grown on the current industry standard - electropolished 316L stainless steel.
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CHAPTER THREE

MATERIALS AND METHODS
3.1 Surface Preparation

Annealed 0.005‖ thick 316L stainless steel specimens (Brown metal company,
Rancho Cucamonga, CA) were divided into three groups – electropolished, as received,
and micro-grooved. While a smooth surface finish was obtained by electropolishing
(Team Metal Finishing, Toccoa, GA), the topography of ―as received‖ samples was not
modified. Micro-grooved surfaces were produced by pasting the as received metal pieces
on to a plastic microscopy slide and placing it on a contact surface grinder (Exakt D2000, Exakt Technologies Inc., Oklahoma, OK). Metallographic grinding for two
minutes using 60 grit silicon carbide paper (Buehler, Lake Bluff, Illinois) produced near
parallel grooves on the surface. Using wire EDM, 1.5 cm diameter discs with a 0.3x0.3
cm square lip were cut from the stainless steel specimens. The square lip was folded to be
perpendicular to the disc surface to facilitate sample handling. The metal discs were first
cleaned with 100% acetone for 20 minutes in an ultrasonic cleaner. They were then
placed in a 1% (by vol.) detergent solution (Liquinox brand, Alconox Inc.) ultrasonicated
for another 20 minutes. The discs were then put through three 15 minute ultrasonic rinse
cycles in ultra pure de-ionized water, where the water was completely exchanged after
each rinse. Air-dried samples were then sterilized using standard procedures of ethylene
oxide sterilization.
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3.2 Surface characterization

Non-contact profilometry (NT-2000, Veeco, WYKO Corp., Tuscon, AZ) was
conducted on each cleaned sample of stainless steel on eight different areas at a
magnification of 25X and a cut-off area of 736µm x 480µm. These measurements
allowed for calculation of various roughness parameters for all of the samples used for
this study including roughness average (Ra), and root mean square roughness (Rq).

Scanning Electron Microscopy (SEM, Model S-3400, Hitachi, Japan) was
performed to visually evaluate the metals surface characteristics. This characterization
tool was utilized to both observe the topography of the metal and to guarantee that
material preparation by-products no longer remained on the metal surface.

Electron dispersive x-rays (EDS, Model S-3400N, Hitachi, Japan) was used to
ascertain a quantitative break down of elements on the sample surface. This procedure
was employed to ensure that the metal being used was in fact 316L stainless steel, with
Palmaz Schatz Stent (Boston Scientific, Natick, MA) used as reference for 316L stainless
steel. Additionally, EDS was conducted to assure that surface treatment did not alter the
material composition.
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3.3 Cell culture

Using an approved protocol by the Institutional Animal Care and Use Committee,
aortas were harvested from 6-10 weeks old female Sprague-Dawley rats. Adventia and
fat layers were peeled off, while endothelium was gently scraped off to leave only medial
layer of aorta.

Rat aortic smooth muscle cells (RASMCs) were collected using

collagenase type II (Worthington Biomedical, Lakewood, NJ), Elastase (Worthington
Biomedical, Lakewood, NJ), and soybean trypsin inhibitor (Worthington Biomedical,
Lakewood, NJ). The cells were maintained in Dulbecco‘s modification of Eagle medium
(DMEM, 10-013-CV; Mediatech, Herndon, VA) supplemented with 10% heatinactivated fetal bovine serum (FBS) (F-4135; Sigma-Aldrich, St. Louis, MO) and 1%
antibiotic-antimycotic (A5955, Sigma-Aldrich, St. Louis, MO) under standard cell
culture conditions (37oC, 5% CO2 with 95% air, humidified environment). 15000
RASMCs were seeded per disc at passage 4-7, with medium replaced every second day.

3.4 Confocal microscopy for F-actin and cell nuclei

At days 1-4, the cells were fixed in a 2% paraformaldehyde solution for 20
minutes, incubated with glycine for 5 minutes, followed by permeabilization with 0.1%
TritonX-100. Cytoskeletal F-actin and cell nuclei were stained using rhodaminephalloidin (Invitrogen, R415) and 4',6-diamidino-2-phenylindole (DAPI) (Molecular
Probes, D-1306, Eugene, OR) for one hour and 10 minutes respectively. Samples were

31

thoroughly washed with PBS and refrigerated after covering with Vectashield Mounting
medium (Vector Laboratories, Burlingame, CA) until imaged using confocal microscopy
(Nikon LV-UDM, Nikon Instruments Inc., Melville, NY).

3.5 Quantification of cell elongation

Measurements of the cells including length, width, minor axis, major axis, and
elongation were performed using NIS Elements 3.1 (Nikon Instruments Inc., Melville,
NY). The elongation of cells was calculated as the ratio between MaxFeret and MinFeret
(maximum or minimum perpendicular distance between parallel tangents touching
opposite sides of the profile of the chosen cells), with 1.0 being a complete circle. A
minimum of 137 cells per group were measured for analysis from random points from
three samples of each of the three experimental groups. The experiment was repeated
once.

3.6 Cell proliferation

3.6.1 CyQuant Cell Proliferation assay

At day 1, 2, 3, and 4, Cell Titer 96 AQueous ONE Solution Cell Proliferation Assay
(MTS) (Promega Corporation, G-3580, Madison, WI) was used to evaluate cell
proliferation. This was done by adding 60 µl of the AQueous One assay solution to each

32

metal disc immersed in 300 µl of serum free DMEM. After incubating for 2hrs, the
supernatant was collected and 100 µl was dispensed into three wells of a 96 well plate for
each of the individual metal discs. The absorbance was then measured at 490 nm
(Beckman Instruments, Inc., Model# DU 640B, Fullerton, CA). Two samples per group
were used, and the experiment was repeated three times.

3.6.2 DAPI Cell count

At day 1, 2, 3, and 4, cells were fixed with cold methanol for 15 minutes,
permiabilzied with 0.1% TritonX-100, and stained with 4',6-diamidino-2-phenylindole
(DAPI) (Molecular Probes, D-1306, Eugene, OR) for 10 minutes. Samples were
thoroughly washed with PBS and images were captured for eight random areas on each
of the three discs of all three surface types (Nikon AZ-100, Nikon Instruments Inc.,
Melville, NY). Cell number was counted for each disc and represented as cell count per
field of view.

3.7 Smooth muscle α-actin expression

α-actin expression in smooth muscle cells grown on stainless steel discs of
varying topography was analyzed using a modified cell-based ELISA assay [75]. Briefly,
at indicated times, the media was removed, and the cells were fixed in cold methanol.
They were then incubated with a blocking solution that consisted of 40mg/ml bovine
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serum albumin in PBS, 6% FBS, and 0.05% Triton-X for 45 minutes at room
temperature. Primary mouse anti-α-actin antibody diluted 1:200 in the blocking solution
was then added to the metal discs for 2 hours at room temperature followed by a 2hr
treatment with biotin conjugated bovine anti-mouse IgG also diluted 1:200 in the
blocking solution. After extensive washing, the cells were incubated with streptavidinconjugated alkaline phosphatase for 45 minutes at 37oC. Chromogenic substrate (3 mM
p-nitrophenyl phosphate, 0.05 M Na2CO3, and 0.05 mM MgCI2) was then applied to
produce color, and the absorbance read at 405 nm with a microplate reader (Beckman
Instruments, Inc., Model# DU 640B, Fullerton, CA). The cells were then DAPI stained
and imaged to facilitate cell counting. Lastly, absorbance due to non-specific binding was
subtracted from that of the experimental groups, with the net absorbance normalized
against cell count on each disc giving a number directly related to the α-actin content per
cell.

3.8 Immunofluorescent staining

Smooth muscle cells on stainless steel discs were fixed with cold methanol and
blocked for 45 minutes at room temperature with a blocking solution that consisted of
40mg/ml bovine serum albumin in PBS, 6% FBS, and 0.05% Triton-X. Cells were then
treated with primary mouse anti-α-actin antibody and fluorescent tagged donkey antimouse secondary antibody, both diluted 1:200 in the blocking solution, for 2 hours and 3
hours respectively at room temperature. The cells were then stained with DAPI
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(Molecular Probes, D-1306, Eugene, OR) to assist in distinguishing individual cells
during fluorescent microscopy (Nikon LV-UDM, Nikon Instruments Inc., Melville, NY).

3.9 Statistical Analysis

Data were evaluated using an ANOVA statistical analysis paired with LSD/Tukey
analysis. This was done using SAS statistical analysis software (SAS Institute Inc., Cary,
NC) with p<0.05 indicating a significant difference.
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CHAPTER FOUR
RESULTS
4.1 Surface characterization

Figure 3 shows representative topographical images of the surface types of
interest to the present study. It is evident that metallographic grinding produced nearparallel grooves, while the surface features on electropolished and as received surfaces
were randomly present throughout the surface. In addition to the topographical images,
quantitative roughness data were acquired from the profilometry analysis, and are
summarized in Table 2. The average Ra (mean±SD) for electropolished, as received and
micro-grooved surfaces was found to be 89.2±8.1nm, 179.±9.9nm, and 2009.8±361.4nm
respectively. A groove depth range of 10.56 µm and 18.0 µm with an average of 12.7 µm
was measured in the micro-grooved surface samples. The relatively higher variability in
all roughness parameters for micro-grooved surfaces is attributed to the heterogeneity of
surface profile imparted by metallographic grinding.

Table2: Roughness values of three surface types
Ra (in nm)
Rq (in nm)
Electropolished

89.2±8.1

110.8±9.7

As Received

179±9.9

226.7±11.7

Micro-grooved

2009.8±361.4

2474.1±4
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(a)

(b)

(c)
Figure 3: Representative topographical images of (a) Electropolished surface, (b) As
Received surface, and (c) Micro-grooved surface.
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Figure 4 shows SEM images of electropolished, as received, and micro-grooved
surfaces in topography mode. For the micro-grooved surfaces, it was rather difficult to
distinguish between individual ―scratches‖ and many of them collectively formed larger
micro-grooves of width 25-30µm. Since this surface had grooves of width and depth in
the micron range, this surface was called the micro-grooved surface.

EDS results did not show any significant differences in elemental composition
between electropolished surface, as received surface, and Palmaz stent made from 316L
stainless steel. Although, the results showed approximately 2.5 wt% carbon in all
specimens tested, this is attributable to contaminants present because of imperfect
vacuum present in the testing system. EDS spectra for all three surface types are shown in
figure 5.
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(a)

(b)

(c)
Figure 4: Representative SEM images of (a) Electropolished surface, (b) As Received
surface, and (c) Micro-grooved surface (images taken at accelerating voltage of 20kV).
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(a)

(b)

(c)
Figure 5: EDS spectra for electropolished (a), as received (b), and micro-grooved (c)
surface
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4.2 Cell morphology

Confocal microscopy of smooth muscle cells grown on stainless steel discs
showed a clear difference in SMC morphology on different surface topographies. While
cells on electropolished and as received surface were round and less elongated, cells on
the micro-grooved surface were found to be aligned in the direction of grooves and
assumed an elongated spindle-shaped morphology starting as early as 24 hours of
incubation. This trend was observed up to day 4, at which point the experiment was
stopped due to near confluence on the discs. Figure 6 shows representative images of for
all four time points.

Quantitative data for cell elongation were obtained by image analysis, and is
shown in figure 7. Cells on all time points were found to be statistically more elongated
on micro-grooved surfaces (p value <0.0001) when compared to both electropolished and
as received surfaces. However, the difference in cell elongation between electropolished
and as received surface types was not statistically significant on any of the four time
points.
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E1

A1

M1

E2

A2

M2

E3

A3

M3

E4

A4

M4

E: Electropolished; A: As received; M: Micro-grooved; 1-4: Day1-Day4; Red: F-Actin; Blue: Nuclei

Figure 6: Representative confocal micrographs of F-actin (Red) and cell nuclei (Blue)
stained SMCs Magnification: 400X; Bar represents 50µm
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Electropolished
As Received
Micro-grooved
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Elongation

*
*

4

*

*
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0
1

2

3

4

Day

Figure 7: Effects of surface topography on cell elongation. Data represents mean values
±SEM, n=3, *p<0.0001 compared to electropolished and as received surfaces at the same
time point.

4.3 Cell proliferation

Although, CyQuant cell proliferation assay showed a lower absorbance (directly
related to cell count) for micro-grooved surface on all four time points compared to the
electropolished as well as as received surface, the differences in absorbance and thus cell
proliferation were not statistically significant (figure 8).
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Electropolished
As Recieved
Micro-grooved
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Figure 8: CyQuant Cell proliferation assay. Data represents mean values ±SD; n=2

However, DAPI cell counting showed a statistically significant difference in cell
count per field of view between electropolished and micro-grooved surface on on day 1
(p-value 0.0068), day 3 (p-value 0.0288) and day 4 (p-value 0.0249). Although average
cell count on micro-grooved surface on day2 was lower than that on electropolished
surface, the difference was not found to be statistically significant (p-value 0.3744).
Micro-grooved surfaces showed approximately 44%, 11.5%, 30.5%, and 20% lower cell
count per field of view when compared to electropolished surface on day 1, 2, 3, and 4
respectively. Differences in cell count between as received surface and micro-grooved
surface were only significant on day 1 (p-value 0.0163) and day 4 (p-value 0.0309),
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where micro-grooved surface showed 54% and 19% lower cell counts per field of view
when compared to the as received surface on day 1 and 4 respectively. Lastly, differences
in cell count between as received and elctropolished surface were not significant on any
of the four time points (figure 9).
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Figure 9: DAPI Cell Count per field of view. Data represents mean values ±SD; n=3;
*p<0.05 compared to electropolished surface at the same time point; #p<0.05 compared
to as received surface at the same time point; **p<0.05 compared to respective surface
types on day1.
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4.4 Cell based ELISA assay

The cell based ELISA assay developed for this application resulted in a number
directly proportional to smooth muscle α-actin content per cell (figure 10). The results
did not show any large differences in α-actin content between the three surface types on
day 1 (p-value 0.5077) and day 2 (p-value 0.7271). As the cells started to reach
confluence, α-actin content per cell on micro-grooved surface started to increase over that
on the electropolished surface with micro-grooved surface demonstrating on an average
approximately 15% higher α-actin content per cell compared to the electropolished
surface on day 3. The difference, however, was found to be statistically insignificant (pvalue 0.2521). On day 4, micro-grooved surface showed approximately 63% higher αactin content when compared to electropolished surface (p-value 0.0318).

Additionally, while α-actin content per cell on the micro-grooved surface on day 1
and day 4 was statistically constant, it decreased 32% between day 4 and day 1 on the
electropolished surface. Although for micro-grooved surface, α-actin content per cell
increased by approximately 20% from day 1 to day 4, the difference was not statistically
significant (p-value 0.2453). Lastly, differences in α-actin content on as received surfaces
were not significantly different from other surface types, and did not change on a time
scale.
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Figure 10: Effect of surface topography on smooth muscle α-actin expression – Cell
based ELISA assay; n=3; *p<0.05 compared to electropolished surface on the same time
point; #p<0.05 compared to same surface type on day1

4.5 Immunofluorescent staining

Immunofluorescent staining also demonstrated that SMCs patterned in the microgrooves appeared elongated and had actin filaments oriented along the direction of the
channels (figure 11). Differences in the intensity of smooth muscle α-actin, however,
were not apparent as with the ELISA assay.
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Figure 11: Effect of topography on α-actin expression – Immunofluorescent staining;
Green: Smooth muscle α-actin; Blue: Cell nuclei; Magnification: 400X; Bar represents
100µm
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CHAPTER FIVE
DISCUSSION

This study was aimed at evaluating the response of rat aortic smooth muscle cells
while in contact with 316L stainless steel of three different topographies, as an attempt to
translate the design criteria previously utilized for improving smooth muscle cell
functions on polymers to the most regularly used metal for stent applications. For
potential applications as tissue engineered vascular grafts, topography of a variety of
polymers has been shown to affect smooth muscle cell response ranging from cell
alignment to one of the most critical requirement of these grafts– cellular phenotype.
Topography as a tool to modulate vascular cell functions, has not been exploited as well
for endovascular stent applications with only one study reported thus far evaluating the
potential of topography for one of the less commonly used stent material – CoCrMo [60].
This study, therefore, reports the valuable effects of micro-grooves on one of the most
commonly used stent material – 316L stainless steel – on the much sought after smooth
muscle cell phenotype.

Over-proliferation, migration and an overall phenotypic shift of smooth muscle
cells following stent deployment has been deemed to be one major cause of restenosis
[17,20-23].

Preserving the contractile phenotype of smooth muscle cells, therefore,

represents one of the two key strategies aimed at limiting restenosis along with promoting
re-endothelialization of stent struts and inter-strut space. Our results indicate that in
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comparison to the current industry standard (electropolishing), micro-grooves on 316L
stainless steel promotes elongated morphology, limits proliferation, and promotes α-actin
expression in smooth muscle cells. Since endothelium is denuded following stent
deployment in most cases and stent struts are in direct contact with medial smooth muscle
cells, topographical modification of outer stent surface presents a powerful intrinsic tool
to control adverse smooth muscle cell response that leads to restenosis.

Near parallel micron level grooves in stainless steel were produced by
metallographic grinding, while elctropolishing produced a relatively smooth surface
finish. Non-contact profilometry indicated that the average surface roughness of as
received surface type was about twice that of the electropolished surface, while that of
the micro-grooved surface was more than 20 times compared to the electropolished
surface. SEM images also showed the difference in topography between the surface
types, while EDS confirmed not only that the material acquired for this study was similar
to that of Palmaz stent, i.e. 316L stainless steel, but also that our surface modification
process did not produce any variations in material composition. Thus, all the differences
in cell behavior reported in this study are attributable to the differences in topography
alone.

Cell-shape has been shown to be an important determinant of cell growth,
alignment, migration, and differentiation for a variety of cell types including vascular
smooth muscle cells. Recent studies have shown that micro-grooves restrict SMC
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spreading in one direction resulting in a more elongated morphology [58,65,67]. Our
results indicated the same trend with elongation and alignment along the grooves of depth
~13 µm taking place as early as 24 hours. Thakar and collaborators observed a similar
elongation of SMCs with patterned collagen strips of width 20-30 µm [58]. It is important
to point out the slight dip in cellular elongation on all three surface types from day 3 to
day4. At the current cell seeding density, cells reached confluence on day 4, and we
postulate that it is this confluence that caused the observed decrease in cell elongation.

Since limiting SMC over-proliferation has been a major objective in improving
stent performance, our results have significant implications for stent applications. Microgrooves did limit SMC proliferation when compared to electropolished surface type.
Many researchers have observed this effect with a variety of polymers, with Thakar et al.
demonstrating that elongated cell morphology alone can produce this effect irrespective
of the cell spreading area [63]. Choudhary and collaborators observed an increase in
SMC proliferation due to nanometer range roughness on CoCrMo with an overall
increase in the ratio of endothelial to smooth muscle cells [60]. However, in a stented
artery where there are less endothelial cells compared to smooth muscle cells, the
beneficial effects of using nanometer scale roughness on a rather uncommon stent
material with similar cell seeding densities for both cell types, would remain
questionable.
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The phenotype of SMCs in blood vessels plays an important role in vascular
remodeling under physiological and pathological conditions. For example, during
atherosclerosis and restenosis, SMCs convert from a quiescent contractile phenotype to a
proliferative synthetic phenotype [21-23]. We postulated that by changing substratum
topography, we could control SMC phenotype with our aim being keeping these cells in
their native contractile phenotype. We selected smooth muscle α-actin as a marker of
contractile phenotype, and observed higher α-actin content per cell compared to the
electropolished surface when the cells reached confluence. Amongst the studies reported
by others in relation to response of SMCs to micropatterning, the inability of microgrooves to bring about any changes in cell phenotype [58,63] has been reported, while
there are only a few studies reporting some degree of success in controlling SMC
phenotype with micropatterning alone [66,67]. Other studies did not focus on the
phenotype of cells with an aim to control cell proliferation/adhesion and/or orientation
[60,62,65,76]. Within the first category, Thakar et al. demonstrated that cell shape
controlled cell proliferation for SMCs, but it was insufficient in bringing about significant
changes in α-actin gene expression [63]. However, this study was done with PDMS
(micro-grooves of width 10µm), and protein level changes in α-actin were not studied. In
another study, Thakar et al. observed decreased SMC proliferation in response to micropatterned collagen strips, but these micro-patterned strips were not enough to promote
contractile phenotype [58]. However, data obtained by these authors cannot be directly
compared to the present results, because not only this study involved a different substrate,
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but a large proportion of their substrate area was also unavailable for cell growth since
the strips were only 2-3 cells wide.

Very recently Cao and collaborators reported that SMCs switched to a more
contractile phenotype when cultured on relatively wide microchannels (80-160µm) only
when the cells reached confluence [66]. For the micro-grooved surface, we observed only
a slight increase in α-actin (~20%) content when cells reached confluence (day4) when
compared to day1, with the difference in smooth muscle α-actin content per cell being
significantly different from that on electropolished surface only as the cells became
confluent. Furthermore, it is a common practice to clinically use electropolished stents in
order to minimize thrombus formation. While it has been proven beneficial to
electropolish the inner blood contacting surface of stents, as indicated by our results,
electropolished surface encourages smooth muscle cell differentiation. We demonstrate in
this study that SMCs on electropolished 316L stainless steel lost a significant amount of
smooth muscle α-actin on day 4 compared to day 1, while micro-grooves helped preserve
that α-actin and thus the contractile phenotype. Immunofluorescent imaging showed a
similar trend in that that many cells on electropolished surface had almost no α-actin on
day 4. However, the differences in α-actin between the three surface types were not as
easy to pick up as with the quantitative ELISA assay.
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CHAPTER SIX
CONCLUSIONS

A model was developed to replicate vascular tissue in contact with stent material of
different topographies. Topography of 316L stainless steel was modified using
electropolishing and metallographic grinding, with the surface completely characterized
prior to smooth muscle cell culture. Cellular morphology, proliferation, and expression of
smooth muscle α-actin were described by confocal microscopy, growth curves, and
ELISA assay respectively. Several conclusions can be drawn from this research:

1. Smooth muscle cells aligned along micro-grooves of depth about 13µm, and
became elongated demonstrating morphology closer to that of contractile smooth
muscle cells.
2. Micro-grooves limited smooth muscle cell proliferation when compared to
electropolished and as received surface types.
3. Smooth muscle cells on micro-grooved stainless steel had higher α-actin content
compared to that on electropolished surface near confluence.
4. Smooth muscle cells on electropolished surface lost a substantial amount of αactin between days 1 and 4, while micro-grooved surface preserved the α-actin
and thus the contractile phenotype of smooth muscle cells.
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Results show that micro-grooves approximately 13µm deep on 316L stainless steel
are able to preserve the contractile phenotype of smooth muscle cells while limiting their
proliferation when compared to the current industry standard for bare metal stents –
electropolishing. This research, therefore, demonstrated the potential of micro-grooves on
outer stent surface as an intrinsic tool to prevent neointimal hyperplasia and thus in-stent
restenosis.
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CHAPTER SEVEN
RECOMMENDATIONS

1. Metallographic grinding used in this study permitted limited control over groove
dimensions. Dimensions of micro-grooves should be optimized by generating
precisely controlled surfaces with varying groove orientation, width, depth and
pitch.
2. Blood vessels are constantly subjected to hemodynamic stresses, with the
pulsatile nature of the blood flow resulting in cyclic mechanical strain in the
vessel walls. Since mechanical strain has been shown to regulate vascular SMC
phenotype, functions and matrix remodeling, response of SMCs to micro-grooved
stainless steel while subjected to a cyclic strain stimulus should be evaluated.
3. Migration of smooth muscle cells under the influence of chemoattarctants such as
PDGF-BB is an important event in the progression of neointimal hyperplasia.
Influence of micro-grooved topography on smooth muscle cell migration,
therefore, should be studied.
4. Mechanotransductive pathways involved in the reported phenotypic shift in SMCs
should be probed to gain a better understanding of cell-substratum relationship.
5. Animal studies using micro-grooved stents should be done to confirm if the in
vitro findings would manifest in substantial clinical benefits.
6. Effect of material removal due to topographical modification of stent struts on the
overall radial strength of stents should be evaluated.
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APPENDIX A: Response of SMCs to Hydroxyapatite (HA) coating

Introduction
Since the basic mechanisms governing the interactions between an implant in general,
and stents in specific, with tissues/blood have not yet been deciphered completely, the
biocompatibility and hemocompatibility of stents still remains an issue. Coating the stent
surface with other materials to alter its surface characteristics without interfering with the
bulk properties of the metal stent has been one of the major rational approaches to
address this compatibility issue [77]. Moreover, coatings can be loaded with antiinflammatory and/or anti-coagulant drugs to help reduce thrombosis and neointimal
hyperplasia – the two major events leading to restenosis. While a majority of the coatings
for endovascular stent applications are made of polymers, a number of ceramic coatings
have been investigated for the aforementioned application.

HA, a naturally occurring mineral form of calcium apatite (Ca10(PO4)6(OH)2)
present in various tissues of the body, has been extensively used as implant materials for
orthopedic and dental applications because of its favorable interaction with bones
[78,79]. HA coating for stents is a relatively new idea, but it may be beneficial for several
reasons. First, HA forms a porous coating on the stent surface that can be utilized as a
unique drug delivery platform for drugs such as bisphosphonates that bind avidly to HA.
Recently, Wu et al. demonstrated inhibition of SMC proliferation, adhesion, and
migration by addition of 10-100 µM of Zoledronate – a type of bisphosphonate [80].
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Secondly, HA coating might provide a beneficial surface for stented artery reendothelialization as demonstrated by Okada et al. [81,82]. Additionally, reduction in the
release of metallic ions including nickel from coated implants including nickel-titanium
alloys and stainless steel as compared to a non-coated control has been reported for HA
coating in in-vitro studies [83,84].

Although the effect of HA coating on endothelial cells has been evaluated, its
effects on smooth muscle cells have not been reported. With more smooth muscle than
endothelial cells remaining at the site of stenting [19], evaluating the response of smooth
muscle cells to the stent/coating material becomes very critical in establishing the
prospects of using HA coating for stents. The objective of this study, therefore, is from a
biomaterials perspective to evaluate the response of smooth muscle cells in terms of cell
morphology, proliferation, and phenotype, to HA coating as compared to the current
industry standard for bare metal stents – electropolished 316L stainless steel.
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Materials & methods
Surface preparation
316L stainless steel discs of diameter 1.5 cm were coated with Hydroxyapatite
(Enbio, Ireland). Electropolished 316L stainless steel discs were prepared as described
earlier. The metal discs were first cleaned with 100% acetone for 20 minutes in an
ultrasonic cleaner. They were then placed in a 1% (by vol.) detergent solution (Liquinox
brand, Alconox Inc.) ultrasonicated for another 20 minutes. The discs were then put
through three 15 minute ultrasonic rinse cycles in ultra pure de-ionized water, where the
water was completely exchanged after each rinse. Air-dried samples were then sterilized
using standard procedures of ethylene oxide sterilization.

SEM
Scanning Electron Microscopy (SEM, Model S-3400, Hitachi, Japan) was
performed to visually evaluate the metals surface characteristics. This characterization
tool was utilized to both observe the topography of the coating and to guarantee that a
uniform coating was present on the metal surface.

Cell culture
Using an approved protocol by the Institutional Animal Care and Use Committee,
aortas were harvested from 6-10 weeks old female Sprague-Dawley rats. Adventia and
fat layers were peeled off, while endothelium was gently scraped off to leave medial
layer of aorta.

Rat aortic smooth muscle cells (RASMCs) were collected using
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collagenase type II (Worthington Biomedical, Lakewood, NJ), Elastase (Worthington
Biomedical, Lakewood, NJ), and soybean trypsin inhibitor (Worthington Biomedical,
Lakewood, NJ). The cells were maintained in Dulbecco‘s modification of Eagle medium
(DMEM, 10-013-CV; Mediatech, Herndon, VA) supplemented with 10% heatinactivated fetal bovine serum (FBS) (F-4135; Sigma-Aldrich, St. Louis, MO) and 1%
antibiotic-antimycotic (A5955, Sigma-Aldrich, St. Louis, MO) under standard cell
culture conditions (37oC, 5% CO2 with 95% air, humidified environment). 15000
RASMCs were seeded per disc at passage 4-7, with medium replaced every second day.

Microscopy for F-actin and cell nuclei
At 48 hours, the cells were fixed in a 2% paraformaldehyde solution for 20
minutes, incubated with glycine for 5 minutes, followed by permeabilization with 0.1%
TritonX-100. Cytoskeletal F-actin and cell nuclei were stained using rhodaminephalloidin (Invitrogen, R415) and 4',6-diamidino-2-phenylindole (DAPI) (Molecular
Probes, D-1306, Eugene, OR) for one hour and 10 minutes respectively. Samples were
thoroughly washed with PBS and refrigerated after covering with Vectashield Mounting
medium (Vector Laboratories, Burlingame, CA) until imaged (Nikon LV-UDM, Nikon
Instruments Inc., Melville, NY).

Live/Dead assay
At 48 hours, non adherent cells were removed by gently rinsing with PBS.
Live/Dead assay reagent (Invitrogen Corporation, Carlsbad, CA) that consisted of 4 µM
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EthD-1 and 2 µm Calcein solution in PBS, was then directly added to adherent cells for
45 minutes in dark. Images were then taken using fluorescent imaging with live cells
represented by green color and dead cells with red (Nikon AZ-100, Nikon Instruments
Inc., Melville, NY).

CyQuant Cell Proliferation assay
At days 1, 2, 3, and 4, Cell Titer 96 AQueous ONE Solution Cell Proliferation
Assay (MTS) (Promega Corporation, G-3580, Madison, WI) was used to evaluate cell
proliferation. This was done by adding 60 µl of the AQueous One assay solution to each
metal disc immersed in 300 µl of serum free DMEM. After incubating for 2hrs, the
supernatant was collected and 100 µl was dispensed into three wells of a 96 well plate for
each of the individual metal discs. The absorbance was then measured at 490 nm
(Beckman Instruments, Inc., Model# DU 640B, Fullerton, CA).

Smooth muscle α-actin expression
α-actin expression in smooth muscle cells grown on stainless steel discs of
varying topography was analyzed using a modified cell-based ELISA assay [75]. Briefly,
at indicated times, the media was removed, and the cells were fixed in cold methanol.
They were then incubated with a blocking solution that consisted of 40mg/ml bovine
serum albumin in PBS, 6% FBS, and 0.05% Triton-X for 45 minutes at room
temperature. Primary mouse anti-α-actin antibody diluted 1:200 in the blocking solution
was then added to the metal discs for 2 hours at room temperature followed by a 2hr
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treatment with biotin conjugated bovine anti-mouse IgG also diluted 1:200 in the
blocking solution. After extensive washing, the cells were incubated with streptavidinconjugated alkaline phosphatase for 45 minutes at 37oC. Chromogenic substrate (3 mM
p-nitrophenyl phosphate, 0.05 M Na2CO3, and 0.05 mM MgCI2) was then applied to
produce color, and the absorbance was then read at 405 nm with a microplate reader
(Beckman Instruments, Inc., Model# DU 640B, Fullerton, CA). The cells were then
DAPI stained and imaged to facilitate cell counting. Lastly, absorbance due to nonspecific binding was subtracted from that of the experimental groups, with the net
absorbance normalized against cell count on each disc.

Statistical Analysis
Data was evaluated using an ANOVA statistical analysis paired with Tukey
analysis. This was done using SAS statistical analysis software (SAS Institute Inc., Cary,
NC) with p<0.05 indicating a significant difference.
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Results
SEM
Figure 12 shows representative SEM images of HA coating in topography and 3D
mode. The coating was evenly present throughout the disc with minimal cracks visible.
Furthermore, HA coating presents a rougher surface when compared to electropolished
316L stainless steel (figure 4b).

(a)

(b)

Figure 12: SEM images of HA coating in (a) topography mode; and (b) 3D mode

Cell morphology
Figure 13 shows SMC morphology on HA coating and electroplished 316l
stainless steel at 48 hours. The cells on HA coating were spread out and had numerous
processes compared to bare metal surface.
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HA

ELECTROPOLISHED

Figure 13: Representative micrographs of F-actin (Red) and cell nuclei (Blue) stained
SMCs Magnification: 100X; Bar represents 100µm

Live/Dead assay
Figure 14 shows Live/Dead assay images at 48 hours. More dead cells were
observed on HA coated samples compared to bare metal surface samples.

HA

ELECTROPOLISHED

Figure 14: Representative Live/Dead assay images for (a) HA coating, and (b)
Electropolished 316L stainless steel; Live and dead cells are shown in green and red
respectively; Magnification: 10X; Bar represents 1000µm
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Cell proliferation
CyQuant cell proliferation assay showed lesser cell count on HA coating on all
four time points when compared to the electropolished surface. On an average, HA
coating showed approximately 27.5%, 21%, 34% and 32% lower absorbance (directly
related to cell count) when compared to electropolished surface on day 1, 2, 3, and 4
respectively (figure 15).

Electropolished
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Figure 15: CyQuant Cell proliferation assay. Data represents mean values ±SD; n=3;
*p<0.05 compared to electropolished metal surface at the same time point.
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Cell based ELISA assay
Results from ELISA assay indicate significantly lower smooth muscle α-actin
content per cell compared to the electropolished surface on all four time points. SMCs on
HA coating had on an average 69%, 59%, 62%, and 49.5% lower smooth muscle α-actin
content per cell compared to electropolished surface on days 1, 2, 3, and 4 respectively
(figure 16).
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Figure 16: Effect of HA coating on smooth muscle α-actin expression; n=3; *p<0.05
compared to electropolished metal surface at the same time point.

79

Discussion
Hydroxyapatite (HA) in orthopedic applications has been shown to have a
favorable biologic response, as it does not induce local or systemic toxicity,
inflammation, or foreign body response while promoting integration with bone [79].
Response of osteoblasts, and mesenchymal stem cells to HA have been studied
extensively [85-89], but to the author‘s best knowledge, this study was the first attempt to
elucidate the response of vascular smooth muscle cells to hydroxyapatite for potential
applications as a stent coating material. Cellular morphology, proliferation, and
phenotype were studied as an indicator of neointimal hyperplasia presenting a scenario,
where the finite amount of loaded drug have been released, while the coating itself
remains tightly appositioned against the artery wall.

SEM images (figure 12) show the topography and integrity of coating on the
metal surface. This coating presented smooth muscle cells with a rougher surface when
compared to the electropolished bare metal surface. However, since the chemistry of the
two surface types studied here are different, differences in cell response cannot be
attributed to topography alone. Conversely, this study was aimed at evaluating smooth
muscle response to the coating, without probing in to the causative factors.

Blocking over-proliferation of medial smooth muscle cells presents a very potent
way to limit neointimal hyperplasia. This study demonstrates the merits of hydroxyapatite
coating in limiting smooth muscle cell proliferation over electropolished 316L stainless
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steel by upto 34% (figure 15). Varying trends in osteoblast proliferation to HA have been
reported in the literature primarily based on the coating process. For example, while a
sintered dense HA disc resulted in lower osteoblast cell count compared to plastic control
[90], a conincident microblasting [85] and electrochemical coating process [86] resulted
in greater cell proliferation compared to their respective control surfaces. Studies with
fibroblasts have yielded varying results in terms of proliferation too [91]. An overall
trend pertaining to effects of HA on cellular proliferation remains challenging to
determine, because of more than one variable being included in the study. Roughness
[86], wettability [92], micro-structure [87], and chemical structure [87] of HA coating
have all been shown to affect cellular behavior separately. Furthermore, live/dead assay
images (figure 14) showed considerably higher number of dead cells on the HA coating
when compared to bare metal surface. But, given the problem of over-proliferation of
smooth muscle cells during restenosis, these results might as well manifest in to a
reduction in neointimal hyperplasia. These results, therefore, must be interpreted
carefully, and are subject to further investigation. Despite the mentioned discrepancies in
quantitative cellular response to HA coating, it has almost always been shown to promote
cell spreading with cell types including osteoblasts and fibroblasts possessing many
processes when cultured directly on HA [86,87]. A similar response with rat aortic
smooth muscle cells was observed here (figure 13). This cell morphology was
significantly different on electropolished surface where the cells were less spread with no
processes.
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Perhaps, one of the most important cellular events in the progression of in-stent
restenosis is the phenotypic shift of smooth muscle cells. SMCs convert from a quiescent
contractile phenotype to a proliferative synthetic phenotype while migrating towards
vessel lumen [21-23]. While low SMC proliferation, as observed here, is a trait of
contractile cells, we observed significantly less smooth muscle α-actin content per cell on
HA coating relative to electropolished surface (figure 16). Taken together with a
somewhat triangular morphology of SMCs as seen in figure 13, lower α-actin content on
HA coating is indicative of synthetic SMC phenotype. These results, therefore, raise a
question regarding aptness of the established criteria for distinguishing between
contractile and synthetic smooth muscle cells - morphology, proliferation, and smooth
muscle α-actin as a marker of contractile phenotype. Furthermore, with the main aim of
stent and/or stent coating being to maintain vessel patency, would limiting cell
proliferation per se irrespective of cell phenotype, be substantial in maintaining lumen
patency is a question that needs to be addressed in order to realize the full potential of
hydroxyapatite as a coating material for stents.
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Conclusions
1. Smooth muscle cells on HA coating were more spread and had a lot of processes
when compared to those on electropolished 316L stainless steel.
2. HA coating significantly limited smooth muscle cell proliferation over
electropolished bare metal surface.
3. Relative to bare metal, significantly greater number of dead cells were seen on
HA coating at 48 hours.
4. Smooth muscle cells lost a substantial amount of α-actin upon culturing on HA
coating when compared to bare metal surface.
5. No conclusion can be made on the phenotype of cells since the three established
characteristics of either phenotype have not been met.

Recommendations
1. Keeping into consideration the osteogenic potential of hydroxyapatite, smooth
muscle cell calcification should be evaluated by the expression of osteogenic
markers by standard molecular biology techniques.
2. Since wettability of an implant surface is an important criterion in biological
responses as it controls the adsorption of proteins followed by cell attachment on
the surface, surface tension should be determined using contact angle
measurements.
3. Because of the brittle nature of HA, the post-strain integrity of HA coating should
be studied using electron microscopy.
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4. Response of smooth muscle cells to HA coating while subjected to a cyclic strain
stimulus should be evaluated to simulate hemodynamic stresses.
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APPENDIX B: Cell based ELISA assay protocol
A modified cell based ELISA assay was developed with advice from Dr. JeoungSoo Lee
as well as some additions based on first-hand experience:

1. Fix SMCs growing in 24-well plates with cold methanol (-20oC) for 25 minutes.
2. Rinse wells with PBS three times to remove methanol completely.
3. Block with blocking agent (2gm BSA, 3ml FBS, 25µ TritonX-100, and 47ml
PBS) for 45 minutes at room temperature.
4. Add primary antibody to smooth muscle α-actin (diluted 1:200 in blocking agent)
for 2 hours at room temperature.
Note: Negative control group received blocking agent without any primary antibody
for the same time.
5. Rinse with PBS three times waiting 5 minutes in each washing step to remove any
unbound antibody.
6. Add biotinylated mouse IgG (diluted 1:200 in blocking agent) for 2 hours at room
temperature.
7. Rinse with PBS three times waiting 5 minutes in each washing step to remove any
unbound antibody.
8. Incubate with streptavidin conjugated alkaline phosphatases (diluted 1:500 in
TBST at pH8) for 45 minutes at 37oC.
9. Rinse with PBS three times waiting 5 minutes in each washing step to remove any
unbound enzyme.
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10. Incubate with chromogenic substrate (3 mM p-nitrophenyl phosphate, 0.05 M
Na2CO3, and 0.05 mM MgCI2) for 45 minutes at 37oC.
11. Transfer 100µl of colored product from each well to a 96 well plate and measure
absorbance at 405 nm.
12. Rinse cells with PBS to remove pnpp and add 0.1% DAPI for 10 minutes at room
temperature.
13. Rinse with PBS briefly and take DAPI images for cell counting.
14. Subtract absorbance of respective negative controls from their experimental
counterparts and normalize against cell count on each disc/well.
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